RxPREDiCT is a venture-backed “data-driven Personalized Health and Wellness" company that specializes in the use of genetic testing, next generation Machine Learning, and Artificial Intelligence (AI) algorithms to provide "Individualized Precision Medication, Diet and Exercise Plans."
Based in Cincinnati Ohio, and a 2015 graduate of the city's leading Centrifuse Accelerator, RxPredict has been recognized for its innovative solutions, including being named as 1 of the top 25 Healthcare AI companies by Health Data Management in 2017, as 1 of 106 Start Ups Transforming Healthcare in the Risk Analytics, Medication, Nutrition and Lifestyle category by CBInsights, as a finalist for Outstanding Bioscience Innovation by the Cincinnati Business Courier and as the recipient of Lead Media's Top Emerging Business Award.
RxPREDiCT’s innovations span across various areas that address the underlying root causes that impact patient Health and Wellness outcomes, including Behavioral & Bio Science, Genetics, Disease Conditions & Progression, Medication Effectiveness & Adherence and Patient Behavior Modification.
Our "best of breed" individualized precision Health and Wellness RxGene product line includes MyRxMeds, a pharmacogenomics medication appropriateness and effectiveness test as well as MyRxDiet, a Personalized Nutrigenics Diet and Exercise plan. RxPredicts markets its products directly to consumers (in all states except New York and Maryland) as well as to providers, health networks, payers, pharmacy benefit managers (PBMs), and third party administrators (TPAs).